For stock investors, the Golden Kirin analyst research report offers authoritative, professional, timely, and comprehensive insights to help uncover potential thematic opportunities.
On the evening of October 9, domestic meat processing leader Henan Shuanghui Investment & Development Co., Ltd. (000895.SZ) disclosed an announcement: due to issues including the sale of agricultural products with veterinary drug residues that do not meet quality and safety standards, the company, its controlling subsidiary Wangkui Shuanghui Beidahuang Food Co., Ltd., and relevant directors and senior executives collectively received 8 Administrative Penalty Decisions. Total confiscations and fines amount to approximately 129 million yuan, which is expected to reduce the company's 2026 annual net profit attributable to shareholders by 6.3806 million yuan, though it will not trigger a major violation delisting scenario.
This accountability stems from a food safety incident five months ago. On May 14, 2026, the Heilongjiang Provincial Market Supervision Administration announced that the lincomycin residue in "pork hind leg meat" produced by Wangkui Shuanghui reached 7,700 μg/kg, exceeding the standard by 37.5 times (national standard limit ≤200 μg/kg). This batch of products was sampled on August 28, 2025, and the company's objection to the authenticity of the samples was ruled invalid.
The day after the news escalated, Henan Shuanghui Investment & Development Co., Ltd. (000895.SZ) shares plunged 5%, wiping out approximately 4.5 billion yuan in market value in a single day. On June 5, the State Council Food Safety Office, together with the Ministry of Public Security, the Ministry of Agriculture and Rural Affairs, and the State Administration for Market Regulation, established a working group to supervise the investigation and handling.
From the structure of the penalties, this enforcement exhibits a "penetrating" characteristic: Wangkui Shuanghui, for selling agricultural products with excessive veterinary drug residues, insufficient certified inspectors, and non-compliant production facilities, was ordered to confiscate illegal gains of 1.6539 million yuan and fined 33.0779 million yuan. It was also warned and fined 50,000 yuan for failing to meet the 12-hour pre-slaughter fasting and resting period. Henan Shuanghui Investment & Development Co., Ltd. (000895.SZ), for selling the aforementioned products through its own sales channels, was ordered to confiscate illegal gains of 1.701 million yuan and fined 34.0193 million yuan. It was additionally fined 2 million yuan for failing to establish inspection standards for the "live pig resting period," failing to appoint a food safety director as required, failing to strictly implement testing protocols, and errors in the data statements of its apology declaration. Four senior executives—Chairman Wan Hongwei, President Ma Xiangjie, Vice President Qiao Haili, and Chief Engineer Wang Yufen—were fined a combined 56.3628 million yuan, with Wan Hongwei personally fined 37.6462 million yuan, exceeding any single fine at the company level.
More alarming than the fines are the management loopholes exposed by the penalty decisions: the subsidiary failed to implement the pre-slaughter fasting and resting system, and the parent company had not even established inspection standards for the "live pig resting period"—one end "not resting," the other end "not inspecting." More ironically, the company mistakenly wrote "5,892 head, 38,863 head" as "batches" in its apology statement, which was deemed to constitute false advertising. If it cannot even get its own stated figures right, why should the public trust its quality control?
Based on the announcement data, the net profit impact of 63.8066 million yuan consists of 37.7202 million yuan from the company's own confiscations and fines, and 26.0864 million yuan from Wangkui Shuanghui's confiscations and fines borne at the 75% shareholding ratio. This accounts for approximately 1.25% of the 2025 net profit attributable to shareholders (5.105 billion yuan), so the direct impact is limited. But the deeper cost lies in trust: after the 2011 "clenbuterol" incident, Shuanghui promised that "wherever a slaughterhouse is built, a breeding base will be built." Fifteen years later, the company still follows a "light on breeding, heavy on slaughtering" model, and this latest excessive residue incident was again attributed to "the upstream breeding segment." Since the products were sold through Shuanghui's own channels, the parent company must bear full primary responsibility—"upstream" has never been a break point in the chain of accountability.
Fines can be recorded in profit and loss, and rectification can be listed as a checklist, but there is no timetable for restoring trust.
Comments